Berlin, Germany

Renate Gildenhaar



Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Renate Gildenhaar: Innovator in Bioactive Materials

Introduction

Renate Gildenhaar is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of bioactive materials, particularly in the development of bone replacement materials. With a total of four patents to his name, Gildenhaar's work is recognized for its innovative approach to biotechnology.

Latest Patents

One of Gildenhaar's latest patents focuses on a bone replacement material comprising crystalline and X-ray amorphous phases. This invention relates to an X-ray amorphous-crystalline material with high solubility, which can be utilized as a bioactive bone replacement material and as a substrate material in biotechnology. The material is characterized by its composition, which includes Q-groups of orthophosphate and diphosphate, with specific weight percentages relative to the total phosphorus content. The main crystal phase consists of CaKNa(PO), while secondary crystal phases and X-ray amorphous phases are also present, contributing to the material's unique properties.

Career Highlights

Gildenhaar has worked with notable organizations, including the Bundesanstalt für Materialforschung und -prüfung (BAM). His experience in these institutions has allowed him to advance his research and development in the field of material science.

Collaborations

Throughout his career, Gildenhaar has collaborated with esteemed colleagues such as Georg Berger and Andrea Spitzer. These partnerships have fostered a collaborative environment that enhances innovation and research in bioactive materials.

Conclusion

Renate Gildenhaar's contributions to the field of bioactive materials, particularly in bone replacement technology, highlight his role as a leading inventor. His innovative patents and collaborations continue to influence advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…